BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SEA Countries

OneStudyTeam Expands Global Research Reach to 4,000 Sites Across EMEA, LATAM, and Asia-Pacific

OneStudyTeam, the maker of the patient enrollment management platform StudyTeam, today announced that StudyTeam is now being used by more than 4,000 clinic...

July 17, 2023 | News

Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma

XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...

July 17, 2023 | News

Supply chain security revolution fuels international partnering surge at CPHI South East Asia 2023

Emphasizing this surge in international partnering, the event is expecting a record attendance of over 8,000, with a significant number coming from oversea...

July 06, 2023 | News

Brii Biosciences Expands Hepatitis B Leadership with Comprehensive Portfolio from Prevention to Cure

Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...

July 06, 2023 | News

Cytiva's BioChallenge Empowers Southeast Asian Biotech Startups to Advance Therapeutic Innovations

In an exclusive interview, Prem Mandalapu, General Manager, Commercial, ASEAN at Cytiva, sheds light on Cytiva's BioChallenge and its objective of supporti...

June 15, 2023 | Influencers

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced b...

June 07, 2023 | News

YS Biopharma's PIKA Rabies Vaccine Approved for Phase 3 Clinical Trials by Philippines FDA

The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...

June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Malaysian Genomics Inks Agreement in Expansion to Bangladesh

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic coope...

May 16, 2023 | News

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

May 01, 2023 | News

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

April 26, 2023 | News

CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023

“Historically, we have seen a dual strategy of focusing on China and the US for emerging innovators in China. However, a series of recent setbacks wi...

April 13, 2023 | News

FINN Partners & Galen Growth will Host Digital Health Investment Summit in Boston

Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas Galen Growth, the...

April 12, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

April 12, 2023 | News

Stay Connected